<p>Ingevity（纽约证券交易所代码：NGVT - 获取免费报告）在周五发布给客户和投资者的研究报告中，投资分析师将其目标价格从 55.00 美元上调至 60.00 美元，Benzinga 报道。该公司目前对该股票的评级为 “持平”。Wells Fargo &amp; Company 的目标价格表明，相较于公司之前的收盘价，潜在上涨幅度为 0.91%。</p>
<p>其他分析师最近也对该公司发布了报告。Zacks Research 在周二将 Ingevity 的评级上调至 “持有”。BMO 资本市场在 12 月 10 日的报告中将 Ingevity 的目标价格从 64.00 美元提高至 70.00 美元，并给予该股票 “跑赢大盘” 的评级。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Ingevity 股票的 “卖出（d-）” 评级。最后，Wall Street Zen 在 12 月 6 日的研究报告中将 Ingevity 的评级从 “强力买入” 下调至 “买入”。一位股票研究分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “持有”，共识目标价格为 65.00 美元。</p>
<p><strong>阅读我们最新的 NGVT 股票分析</strong></p>
<h2>Ingevity 股票表现</h2>
<p>周五，NYSE:NGVT 的开盘价为 59.46 美元。该股票的 50 日移动平均价格为 53.35 美元，200 日移动平均价格为 51.19 美元。该公司的市值为 21.4 亿美元，市盈率为-32.62，贝塔值为 1.40。该公司的债务与股本比率为 8.39，速动比率为 0.80，流动比率为 1.27。Ingevity 的 52 周低点为 28.49 美元，52 周高点为 61.77 美元。</p>
<p>Ingevity（纽约证券交易所代码：NGVT - 获取免费报告）最近在 3 月 24 日发布了季度财报。该公司报告每股收益（EPS）为 0.78 美元。该公司在本季度的收入为 3.36 亿美元。Ingevity 的净利润率为-5.14%，股本回报率为 103.69%。作为一个整体，股票分析师预计 Ingevity 在当前财年将发布 4.45 美元的每股收益。</p>
<h2>机构投资者对 Ingevity 的看法</h2>
<p>几家对冲基金和其他机构投资者最近买入和卖出了该公司的股票。Amalgamated Bank 在第三季度将其在 Ingevity 的股份提高了 1.7%。Amalgamated Bank 现在拥有 10,593 股该公司的股票，价值 585,000 美元，此前在上个季度购买了额外的 180 股。Wealth Enhancement Advisory Services LLC 在第三季度将其在 Ingevity 的持股增加了 3.1%。Wealth Enhancement Advisory Services LLC 现在拥有 7,823 股该公司的股票，价值 418,000 美元，此前在上个季度购买了额外的 238 股。EverSource Wealth Advisors LLC 在第三季度将其在 Ingevity 的股份提高了 15.7%。EverSource Wealth Advisors LLC 现在拥有 1,870 股该公司的股票，价值 103,000 美元，此前在上个季度购买了额外的 254 股。Advisory Services Network LLC 在第三季度将其在 Ingevity 的持股提高了 4.4%。Advisory Services Network LLC 现在拥有 6,947 股该公司的股票，价值 383,000 美元，此前在上个季度购买了额外的 293 股。最后，BI 资产管理基金公司在第一季度将其在 Ingevity 的持股提高了 21.6%。BI 资产管理基金公司现在拥有 1,670 股该公司的股票，价值 66,000 美元，此前在上个季度购买了额外的 297 股。目前 91.59% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Ingevity 公司简介</h2>
<p>（获取免费报告）</p>
<p>Ingevity 公司在北美、亚太地区、欧洲、中东、非洲和南美制造和销售活性炭产品、衍生特种化学品和工程聚合物。它通过三个部门运营：性能材料、性能化学品和先进聚合物技术。</p>
<h2>特色故事</h2>
<ul>
<li>我们更看好的五只股票比 Ingevity 更好</li>
<li>道琼斯工业平均指数（DJIA）是什么？</li>
<li>Rocket Lab 的强劲反弹：近期动能背后的原因</li>
<li>特殊目的收购公司（SPAC）你需要知道的事项</li>
<li>Jabil 在雷达下飞行——但可能会迎来 50% 的激增</li>
<li>如何购买黄金股票并投资黄金</li>
<li>高通的巨大反弹有一个隐患——股票能否继续上涨？</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Ingevity 吗？</h2>
<p>在你考虑 Ingevity 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Ingevity 并不在名单上。</p>
<p>虽然 Ingevity 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

NGVT

<p>富国银行将 Ingevity 股票的目标价从 55.00 美元上调至 60.00 美元，维持 “持平” 评级。其他分析师的评级各不相同，普遍维持 “持有” 评级，目标价为 65.00 美元。Ingevity 的股票开盘价为 59.46 美元，市值为 21.4 亿美元。机构投资者持有 91.59% 的股份。该公司在性能材料、性能化学品和先进聚合物技术领域运营</p>

<p>Ingevity (NYSE:NGVT - Get Free Report) had its price target raised by investment analysts at Wells Fargo &amp; Company from $55.00 to $60.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an &#34;equal weight&#34; rating on the stock. Wells Fargo &amp; Company's price objective would indicate a potential upside of 0.91% from the company's previous close.</p>
<div class="lb-trans"><p>Ingevity（纽约证券交易所代码：NGVT - 获取免费报告）在周五发布给客户和投资者的研究报告中，投资分析师将其目标价格从 55.00 美元上调至 60.00 美元，Benzinga 报道。该公司目前对该股票的评级为 “持平”。Wells Fargo &amp; Company 的目标价格表明，相较于公司之前的收盘价，潜在上涨幅度为 0.91%。</p>
</div><p>Other analysts also recently issued reports about the company. Zacks Research upgraded Ingevity to a &#34;hold&#34; rating in a report on Tuesday. BMO Capital Markets increased their price target on Ingevity from $64.00 to $70.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, December 10th. Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Ingevity in a research note on Wednesday, October 8th. Finally, Wall Street Zen downgraded shares of Ingevity from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, December 6th. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $65.00.</p>
<div class="lb-trans"><p>其他分析师最近也对该公司发布了报告。Zacks Research 在周二将 Ingevity 的评级上调至 “持有”。BMO 资本市场在 12 月 10 日的报告中将 Ingevity 的目标价格从 64.00 美元提高至 70.00 美元，并给予该股票 “跑赢大盘” 的评级。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Ingevity 股票的 “卖出（d-）” 评级。最后，Wall Street Zen 在 12 月 6 日的研究报告中将 Ingevity 的评级从 “强力买入” 下调至 “买入”。一位股票研究分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “持有”，共识目标价格为 65.00 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on NGVT</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 NGVT 股票分析</strong></p>
</div><h2>Ingevity Stock Performance</h2>
<div class="lb-trans"><h2>Ingevity 股票表现</h2>
</div><p>NYSE:NGVT opened at $59.46 on Friday. The stock has a fifty day moving average price of $53.35 and a 200-day moving average price of $51.19. The company has a market cap of $2.14 billion, a price-to-earnings ratio of -32.62 and a beta of 1.40. The company has a debt-to-equity ratio of 8.39, a quick ratio of 0.80 and a current ratio of 1.27. Ingevity has a fifty-two week low of $28.49 and a fifty-two week high of $61.77.</p>
<div class="lb-trans"><p>周五，NYSE:NGVT 的开盘价为 59.46 美元。该股票的 50 日移动平均价格为 53.35 美元，200 日移动平均价格为 51.19 美元。该公司的市值为 21.4 亿美元，市盈率为-32.62，贝塔值为 1.40。该公司的债务与股本比率为 8.39，速动比率为 0.80，流动比率为 1.27。Ingevity 的 52 周低点为 28.49 美元，52 周高点为 61.77 美元。</p>
</div><p>Ingevity (NYSE:NGVT - Get Free Report) last released its quarterly earnings results on Friday, March 24th. The company reported $0.78 earnings per share (EPS) for the quarter. The firm had revenue of $336.00 million during the quarter. Ingevity had a negative net margin of 5.14% and a positive return on equity of 103.69%. As a group, equities analysts anticipate that Ingevity will post 4.45 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Ingevity（纽约证券交易所代码：NGVT - 获取免费报告）最近在 3 月 24 日发布了季度财报。该公司报告每股收益（EPS）为 0.78 美元。该公司在本季度的收入为 3.36 亿美元。Ingevity 的净利润率为-5.14%，股本回报率为 103.69%。作为一个整体，股票分析师预计 Ingevity 在当前财年将发布 4.45 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Ingevity</h2>
<div class="lb-trans"><h2>机构投资者对 Ingevity 的看法</h2>
</div><p>Several hedge funds and other institutional investors have recently bought and sold shares of the business. Amalgamated Bank raised its stake in shares of Ingevity by 1.7% in the 3rd quarter. Amalgamated Bank now owns 10,593 shares of the company's stock valued at $585,000 after purchasing an additional 180 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in Ingevity by 3.1% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 7,823 shares of the company's stock valued at $418,000 after buying an additional 238 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in Ingevity by 15.7% during the third quarter. EverSource Wealth Advisors LLC now owns 1,870 shares of the company's stock valued at $103,000 after buying an additional 254 shares in the last quarter. Advisory Services Network LLC lifted its holdings in Ingevity by 4.4% during the 3rd quarter. Advisory Services Network LLC now owns 6,947 shares of the company's stock worth $383,000 after buying an additional 293 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Ingevity by 21.6% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 1,670 shares of the company's stock worth $66,000 after buying an additional 297 shares during the last quarter. 91.59% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近买入和卖出了该公司的股票。Amalgamated Bank 在第三季度将其在 Ingevity 的股份提高了 1.7%。Amalgamated Bank 现在拥有 10,593 股该公司的股票，价值 585,000 美元，此前在上个季度购买了额外的 180 股。Wealth Enhancement Advisory Services LLC 在第三季度将其在 Ingevity 的持股增加了 3.1%。Wealth Enhancement Advisory Services LLC 现在拥有 7,823 股该公司的股票，价值 418,000 美元，此前在上个季度购买了额外的 238 股。EverSource Wealth Advisors LLC 在第三季度将其在 Ingevity 的股份提高了 15.7%。EverSource Wealth Advisors LLC 现在拥有 1,870 股该公司的股票，价值 103,000 美元，此前在上个季度购买了额外的 254 股。Advisory Services Network LLC 在第三季度将其在 Ingevity 的持股提高了 4.4%。Advisory Services Network LLC 现在拥有 6,947 股该公司的股票，价值 383,000 美元，此前在上个季度购买了额外的 293 股。最后，BI 资产管理基金公司在第一季度将其在 Ingevity 的持股提高了 21.6%。BI 资产管理基金公司现在拥有 1,670 股该公司的股票，价值 66,000 美元，此前在上个季度购买了额外的 297 股。目前 91.59% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Ingevity Company Profile</h2>
<div class="lb-trans"><h2>Ingevity 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.</p>
<div class="lb-trans"><p>Ingevity 公司在北美、亚太地区、欧洲、中东、非洲和南美制造和销售活性炭产品、衍生特种化学品和工程聚合物。它通过三个部门运营：性能材料、性能化学品和先进聚合物技术。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>特色故事</h2>
</div><ul>
<li>Five stocks we like better than Ingevity</li>
<li>What is the Dow Jones Industrial Average (DJIA)?</li>
<li>Rocket Lab's Sharp Rebound: What's Behind the Recent Momentum</li>
<li>Special Purpose Acquisition Company (SPAC) What You Need to Know</li>
<li>Jabil Is Flying Under the Radar—But a 50% Surge May Be Coming</li>
<li>How to Buy Gold Stock and Invest in Gold</li>
<li>Qualcomm’s Monster Rally Has a Catch—Can the Stock Keep Climbing?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Ingevity 更好</li>
<li>道琼斯工业平均指数（DJIA）是什么？</li>
<li>Rocket Lab 的强劲反弹：近期动能背后的原因</li>
<li>特殊目的收购公司（SPAC）你需要知道的事项</li>
<li>Jabil 在雷达下飞行——但可能会迎来 50% 的激增</li>
<li>如何购买黄金股票并投资黄金</li>
<li>高通的巨大反弹有一个隐患——股票能否继续上涨？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Ingevity Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Ingevity 吗？</h2>
</div><p>Before you consider Ingevity, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Ingevity 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingevity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Ingevity 并不在名单上。</p>
</div><p>While Ingevity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Ingevity 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

富国银行公司预测 Ingevity（NYSE:NGVT）股票将迎来强劲的价格升值